AI assistant
Al Hammadi Holding — Capital/Financing Update 2021
Oct 11, 2021
53361_rns_2021-10-11_496a4230-1839-4787-8187-2bd885c97771.html
Capital/Financing Update
Open in viewerOpens in your device viewer
Al Hammadi Company for Development and Investment Announces the latest developments regarding the signing of an agreement to purchase 35% of Sudair Pharmaceutical Company
4007 · 11/10/2021 08:53:02 · Announcement #65114 · View on Saudi Exchange
Al Hammadi Company for Development and Investment Announces the latest developments regarding the signing of an agreement to purchase 35% of Sudair Pharmaceutical Company
| Element List | Explanation |
|---|---|
| Announcement Detail | Hammadi Company for Development and Investment announces that the General Authority for Competition has issued its decision (with no objections) regarding the agreement to purchase 35% of Sudair Pharmaceutical Company, the Hammadi Company will complete the acquisition procedures and announce the completion of the deal in a timely manner |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.